Results 181 to 190 of about 198,192 (354)

Measuring the performance of hedge funds : evidence from hedge fund indices

, 2011
Αντωνία Δ. Δαμαλίτη
openalex   +1 more source

Mutual Funds as Monitors: Evidence from Mutual Fund Voting

, 2010
Angela Morgan, Annette B. Poulsen, Jack G. Wolf, Tina Yang   +3 more
openalex   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Rapid treatment of depression with potassium supplementation: relative deficiency of potassium ions and possible pathogenesis-a case report. [PDF]

J Med Case Rep
Dai J.
europepmc   +1 more source

Active and passive funds: excess returns and persistence in performance - Evidence from the Swedish fund market 2000-2011 -

, 2012
Elisa Halonen, Anna Ljungberg
openalex   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Mutual Fund Returns and Their Characteristics: A Novel Approach to Picking Better Performing Actively Managed Funds

, 2019
Burton G. Malkiel, Atanu Saha
openalex   +1 more source

On Persistence in Mutual Fund Performance

, 1997
Mark M. Carhart
semanticscholar   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Molecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié, Davod R. Shah, Eliane E. S. Brechbühl, Michael McNicholas, Zhaoyang Xu, John H. Stockley, Laura Morcom, Diana Gold Diaz, Gemma C. Girdler, Rachel V. Seear, Gabriel Balmus, Rajiv R. Ratan, Harry Bulstrode, James A. Nathan, Manav Pathania, Kevin M. Brindle, David H. Rowitch   +16 more
wiley   +1 more source

Correction: Lysionotin attenuates bleomycin-induced pulmonary fibrosis by activating AMPK/Nrf2 pathway. [PDF]

Sci Rep
Zhang X, Xiong D, Deng L, Qian R, Tang S, Liu W, Li Y, Liu L, Xie W, Lin M.   +9 more
europepmc   +1 more source